Oregon Public Employees Retirement Fund grew its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 2.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,484 shares of the medical equipment provider’s stock after acquiring an additional 615 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Zimmer Biomet Holdings were worth $2,516,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. BlackRock Inc. lifted its position in shares of Zimmer Biomet Holdings by 4.1% in the 2nd quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock worth $2,236,657,000 after acquiring an additional 679,080 shares during the period. Vanguard Group Inc. raised its holdings in shares of Zimmer Biomet Holdings by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 13,380,517 shares of the medical equipment provider’s stock worth $1,718,057,000 after buying an additional 339,106 shares in the last quarter. Longview Partners Guernsey LTD raised its holdings in shares of Zimmer Biomet Holdings by 17.7% in the 3rd quarter. Longview Partners Guernsey LTD now owns 7,506,684 shares of the medical equipment provider’s stock worth $878,958,000 after buying an additional 1,128,973 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of Zimmer Biomet Holdings by 8.1% in the 3rd quarter. American Century Companies Inc. now owns 4,165,353 shares of the medical equipment provider’s stock worth $487,721,000 after buying an additional 311,654 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in shares of Zimmer Biomet Holdings by 20.2% in the 2nd quarter. Northern Trust Corp now owns 4,010,274 shares of the medical equipment provider’s stock worth $514,919,000 after buying an additional 673,079 shares in the last quarter. Institutional investors own 85.44% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at $110.75 on Monday. The company has a market capitalization of $22,420.00, a price-to-earnings ratio of 13.72, a PEG ratio of 1.72 and a beta of 1.17. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78.

Zimmer Biomet Holdings (NYSE:ZBH) last released its earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). The firm had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet Holdings had a net margin of 8.36% and a return on equity of 16.29%. The firm’s quarterly revenue was down .8% on a year-over-year basis. During the same period last year, the business posted $1.79 earnings per share. sell-side analysts predict that Zimmer Biomet Holdings, Inc. will post 8.03 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Oregon Public Employees Retirement Fund Increases Holdings in Zimmer Biomet Holdings, Inc. (ZBH)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/oregon-public-employees-retirement-fund-increases-holdings-in-zimmer-biomet-holdings-inc-zbh/1699861.html.

ZBH has been the subject of a number of recent research reports. SunTrust Banks, Inc. set a $136.00 target price on Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Wednesday, November 1st. Royal Bank Of Canada dropped their target price on Zimmer Biomet Holdings to $125.00 and set an “outperform” rating for the company in a report on Tuesday, November 7th. BidaskClub cut Zimmer Biomet Holdings from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Piper Jaffray Companies reissued a “buy” rating and issued a $135.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 28th. Finally, Zacks Investment Research cut Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $134.00.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.